- The global clinical trial consumables market is growing as more clinical studies need reliable materials for accurate results. For instance, late-stage trials use many consumables to ensure patient safety and data quality
- Advances in manufacturing and materials are making consumables safer and more efficient and new products improve compatibility with complex trial protocols, supporting market growth
- North America is expected to dominate the clinical trial consumables market with market share of 43.88% primarily due to its advanced healthcare infrastructure and significant investments in research and development
- Asia-pacific is expected to be the fastest growing region in the clinical trial consumables market during the forecast period due to increasing clinical research activities and a large patient population
- The phase III segment is expected to dominate the clinical trial consumables market with the largest share of 53.08% in 2025 due to high number of participants involved, extended trial duration, and increased volume of consumables required for large-scale safety and efficacy assessments before regulatory approval
